Relay Therapeutics
About Relay Therapeutics
Relay Therapeutics is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies. They focus on making small molecule medicines against precision medicine targets, with an initial focus on oncology and genetic disease.
Company Details
- Website
- https://www.relaytx.com
- Funding
- IPO
- Total Raised
- $457M
- Stock Ticker
- RLAY
- https://www.linkedin.com/company/relay-therapeutics
Specializations
- Precision Medicine
- Oncology
- Drug Discovery
- Biotechnology
- Genetic Disease
Products & Solutions (2)
| Product | Category | Sub-Category | Description |
|---|---|---|---|
| Fabry Disease Program (αGal) | research-development | Drug Discovery AI | Advancing a preclinical genetic therapy for Fabry Disease. |
| Relay Platform | research-development | Drug Discovery AI | Motion-based drug design for precision oncology |